Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Kymera Therapeutics Announces Upsized Initial Public Offering
WATERTOWN, Mass., Aug. 20, 2020 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel sm…
Verastem Agrees to Sell Duvelisib Rights to Secura Bio
BOSTON - Aug. 10, 2020 - Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medici…
Ryvu Therapeutics Raises Over $36 Million
Krakow, Poland – July 22, 2020 – Ryvu Therapeutics [RVU], a clinical stage biopharmaceutical company developing novel small molecule therapies that ad…
Cobomarsen Received Orphan Drug Designation from the U.S. FDA for the Treatment of T-cell Lymphoma
BOULDER, Colo., July 23, 2020 - miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and dev…
BioTheryX Announces $35 Million Series D Financing
SAN DIEGO, CA, July 28, 2020 — BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation to treat difficult d…
Media resources
Email
Contact us for inquiries and interview requests.
Press Kit
Explore details for journalists and media outlets.
Brand Center
Access approved logos, guidelines, and other assets.